# A Clinical Study of GK02 in Malignant Ascites

> **NCT07378436** · EARLY_PHASE1 · RECRUITING · sponsor: **Beijing Geekgene Technology Co., LTD** · enrollment: 9 (estimated)

## Conditions studied

- Malignant Ascites Caused by Advanced Solid Tumors

## Interventions

- **DRUG:** GK02

## Key facts

- **NCT ID:** NCT07378436
- **Lead sponsor:** Beijing Geekgene Technology Co., LTD
- **Sponsor class:** INDUSTRY
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-16
- **Primary completion:** 2026-12-17
- **Final completion:** 2027-12-17
- **Target enrollment:** 9 (ESTIMATED)
- **Last updated:** 2026-01-30

## Collaborators

- Beijing GoBroad Hospital

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07378436

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07378436, "A Clinical Study of GK02 in Malignant Ascites". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT07378436. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*